- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Eltrombopag – March 2011
Eltrombopag, tablets, 25 mg and 50 mg, (as olamine), Revolade® - March 2011
Last updated
1 July 2011